» Articles » PMID: 30171279

Global Trends in Diabetes Complications: a Review of Current Evidence

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2018 Sep 2
PMID 30171279
Citations 528
Authors
Affiliations
Soon will be listed here.
Abstract

In recent decades, large increases in diabetes prevalence have been demonstrated in virtually all regions of the world. The increase in the number of people with diabetes or with a longer duration of diabetes is likely to alter the disease profile in many populations around the globe, particularly due to a higher incidence of diabetes-specific complications, such as kidney failure and peripheral arterial disease. The epidemiology of other conditions frequently associated with diabetes, including infections and cardiovascular disease, may also change, with direct effects on quality of life, demands on health services and economic costs. The current understanding of the international burden of and variation in diabetes-related complications is poor. The available data suggest that rates of myocardial infarction, stroke and amputation are decreasing among people with diabetes, in parallel with declining mortality. However, these data predominantly come from studies in only a few high-income countries. Trends in other complications of diabetes, such as end-stage renal disease, retinopathy and cancer, are less well explored. In this review, we synthesise data from population-based studies on trends in diabetes complications, with the objectives of: (1) characterising recent and long-term trends in diabetes-related complications; (2) describing regional variation in the excess risk of complications, where possible; and (3) identifying and prioritising gaps for future surveillance and study.

Citing Articles

Clinical metabolomics in type 2 diabetes mellitus: from pathogenesis to biomarkers.

Liu C, Chen H, Ma Y, Zhang L, Chen L, Huang J Front Endocrinol (Lausanne). 2025; 16:1501305.

PMID: 40070584 PMC: 11893406. DOI: 10.3389/fendo.2025.1501305.


The nonlinear relationship between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol and the risk of diabetic kidney disease in patients with type 2 diabetes mellitus.

Cai D, Huang Y, Lin N, Zhang Y, Huang S, Han Y Front Med (Lausanne). 2025; 12:1492483.

PMID: 40046913 PMC: 11880278. DOI: 10.3389/fmed.2025.1492483.


Development and validation of a risk assessment tool for uncontrolled type 2 diabetes among patients in South Karnataka, India.

Anil D, Doddaiah S, Shivaswamy R, Gopi A, Basheer S, Narayana Murthy M BMJ Public Health. 2025; 2(1):e000717.

PMID: 40018133 PMC: 11812843. DOI: 10.1136/bmjph-2023-000717.


Association between obstructive sleep apnea hypopnea syndrome and arteriosclerosis in patients with type 2 diabetes mellitus: mediating effect of blood pressure.

Wang X, Huang X, Xing Y, Jiang X, Hua F Front Endocrinol (Lausanne). 2025; 16:1510737.

PMID: 40013309 PMC: 11860091. DOI: 10.3389/fendo.2025.1510737.


Potential α-glucosidase inhibitors from cultures of Biscogniauxia capnodes SWUF15-40 fungus.

Churat A, Katrun P, Laohpongspaisan C, Mongkolthanaruk W, Champasri C, Moontragoon P J Nat Med. 2025; .

PMID: 40009286 DOI: 10.1007/s11418-025-01876-9.


References
1.
Munoz-Rivas N, Mendez-Bailon M, Hernandez-Barrera V, de Miguel-Yanes J, Jimenez-Garcia R, Esteban-Hernandez J . Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012). PLoS One. 2015; 10(12):e0145535. PMC: 4700977. DOI: 10.1371/journal.pone.0145535. View

2.
Bullock A, Burrows N, Narva A, Sheff K, Hora I, Lekiachvili A . Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives - United States, 1996-2013. MMWR Morb Mortal Wkly Rep. 2017; 66(1):26-32. PMC: 5687264. DOI: 10.15585/mmwr.mm6601e1. View

3.
Green A, Sortso C, Jensen P, Emneus M . Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000-2011: results from the Diabetes Impact Study 2013. Clin Epidemiol. 2015; 7:421-30. PMC: 4629954. DOI: 10.2147/CLEP.S88577. View

4.
Read S, Kerssens J, McAllister D, Colhoun H, Fischbacher C, Lindsay R . Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia. 2016; 59(10):2106-13. PMC: 5016553. DOI: 10.1007/s00125-016-4054-9. View

5.
Fisher L, Skaff M, Mullan J, Arean P, Glasgow R, Masharani U . A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med. 2009; 25(9):1096-101. PMC: 2635496. DOI: 10.1111/j.1464-5491.2008.02533.x. View